MFG
CYTK icon

Magnus Financial Group’s Cytokinetics CYTK Stock Holding History

Magnus Financial Group’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-12,067
Closed -$284K – 389
2020
Q2 		$284K Hold
12,067
– – 0.03% 381
2020
Q1 		$142K Buy
12,067
+247
+2% +$3.15K 0.02% 497
2019
Q4 		$125K Hold
11,820
– – 0.02% 547
2019
Q3 		$135K Hold
11,820
– – 0.03% 482
2019
Q2 		$133K Hold
11,820
– – 0.03% 494
2019
Q1 		$96K Hold
11,820
– – 0.02% 490
2018
Q4 		$75K Buy
+11,820
New +$86.7K 0.02% 415

Other funds holding CYTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Magnus Financial Group's CYTK Position: Q3 2020 in Review

Magnus Financial Group sold out of Cytokinetics (CYTK) in Q3 2020, closing a stake of 12,067 shares — an estimated $284K sold.

Magnus Financial Group first reported a position in CYTK in Q4 2018 and held it in 7 quarters. The position peaked at $284K in Q2 2020. 181 funds tracked by Wall St. Rank hold CYTK as of Q3 2020.

  • Magnus Financial Group reported no remaining Cytokinetics position as of Q3 2020 after selling out during the quarter.
  • Magnus Financial Group sold 12,067 Cytokinetics shares in Q3 2020, an estimated $284K.
  • Magnus Financial Group first reported a position in Cytokinetics in Q4 2018 and held it in 7 quarters.
  • Magnus Financial Group's Cytokinetics position peaked at $284K in Q2 2020.
  • 181 funds tracked by Wall St. Rank held Cytokinetics as of Q3 2020.

Based on Magnus Financial Group's 13F filing for Q3 2020, filed 5 Nov 2020.